Alzheimer's disease drug development pipeline: 2022

Alzheimer's disease drug development pipeline: 2022

Abstract Introduction Alzheimer's disease (AD) represents a global health crisis. Treatments are needed to prevent, delay the onset, slow the progression, improve cognition, and reduce behavioral disturbances of AD. We review the current clinical trials and drugs in development for the treatmen...

Full description

Bibliographic Details
Main Authors: Jeffrey Cummings, Garam Lee, Pouyan Nahed, Mina Esmail Zadeh Nojoo Kambar, Kate Zhong, Jorge Fonseca, Kazem Taghva
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
aducanumab
Alzheimer's disease
amyloid
biomarkers
clinical trials
Common Alzheimer's Disease Research Ontology (CADRO)
Online Access:https://doi.org/10.1002/trc2.12295

Internet

https://doi.org/10.1002/trc2.12295

Similar Items